Test Price
2,800 AED✅ Home Collection Available
HOXA13 Gene Hand‑Foot‑Uterus Syndrome Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing with deep coverage and in‑silico validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation session with a genetic counsellor – results explained in simple, actionable terms.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731. Most major UAE insurers accepted.
Test Overview & Methodology
The HOXA13 gene hand‑foot‑uterus syndrome NGS test detects pathogenic variants linked to this rare autosomal dominant disorder, which can cause limb malformations and Müllerian duct anomalies. Using next‑generation sequencing (NGS) with full exon coverage, it provides a definitive molecular diagnosis for affected individuals and at‑risk family members.
| Feature | Our Test – HOXA13 NGS (UAE) | Closest Alternative |
|---|---|---|
| Precision | 99.9% sensitivity for SNVs/indels, validated by Sanger confirmation | Single‑gene sequencing / limited panels – may miss rare variants |
| Methodology | NGS (Next‑Generation Sequencing) with full bioinformatic annotation | Sanger sequencing (single exon at a time), slower and less comprehensive |
| Turnaround | 3–4 Weeks | Often 6–8 weeks for multi‑step approaches |
| Regulatory Compliance | DHA‑licensed, ISO 9001:2015, UAE PDPL secure | May not meet UAE genetic test law standards |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Geneticist, I emphasize that the HOXA13 NGS test provides a definitive molecular diagnosis, but it must be interpreted within the full clinical context, including family history and imaging. Always consult with a specialist before making any medical decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Do not discontinue any prescribed medication without consulting your doctor.
Test Exclusion Criteria & Red Flags
- Not suitable for: Emergency diagnosis, prenatal aneuploidy screening (NIPT), or forensic identification.
- Pre‑requisites: A pre‑test genetic counselling session to draw a pedigree chart must be completed. Clinical history mandatory.
- Red Flags – Seek Immediate Medical Attention: If you experience acute limb pain, sudden swelling, or abnormal uterine bleeding before or after sample collection, go to the nearest emergency room. This test does not replace urgent clinical care.
- Sample rejection: Inadequate whole blood volume, incorrect anticoagulant, or FTA card with insufficient dried blood spot. Test not intended for minors without parental consent per applicable UAE regulations.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the HOXA13 hand‑foot‑uterus syndrome NGS test?
This test confirms the molecular diagnosis of hand‑foot‑uterus syndrome by detecting disease‑causing mutations in the HOXA13 gene in individuals with suggestive limb and uterine malformations.
2. Can this be performed on a one‑drop blood sample on an FTA card?
Yes, our accredited laboratory accepts either 2‑3 mL whole blood in EDTA or a properly dried blood spot on an FTA card, providing the same high diagnostic accuracy.
3. How does UAE genetic testing law protect my data and results?
Under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, all genetic data is securely encrypted, stored on UAE‑based servers, and never shared without your explicit consent.
UAE Regulatory & Data Privacy Adherence
Data Protection Compliance: All genetic and personal data are processed in full accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your information is encrypted, stored on UAE‑based servers, and never shared without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | HOXA13 Gene Hand‑Foot‑Uterus Syndrome NGS Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (2‑3 mL EDTA) or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with full exon coverage and CNV detection |
| ICD-10-CM Code | Q87.2, Q87.8, N97.9 |
| LOINC Code | 94076-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians